Far Infrared Radiation Treatment for Bipolar Condition

NCT ID: NCT00573196

Last Updated: 2009-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-09-30

Study Completion Date

2008-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A preliminary study to determine the possibility of using far infrared radiation for the treatment of the Bipolar Condition

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A 2000 study in the American Journal of Psychiatry reported that, "in those with bipolar, two major areas of the brain contain 30 percent more cells that send signals to other brain cells". This fact explains why famous people with the Bipolar condition like astronaut Buzz Aldrin, financier Robert Campeau, British Prime Minister Winston Churchill, composer Mozart, scientist Isaac Newton, physician Sigmund Freud and media giant \& entrepreneur Ted Turner, excelled in life due to the additional brain power!

The excessive brain power, however, had to be controlled occasionally with mood stabilizers. Mood stabilizers include a number of anticonvulsants and Lithium. These medications, however, have adverse side effects on the kidneys. The proposed evaluation does not have any adverse health effects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

Far infrared

Intervention Type RADIATION

Far infrared radiation (5μm to 15μm wavelength)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Far infrared

Far infrared radiation (5μm to 15μm wavelength)

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persons with Bipolar Condition, Depression, Anxiety, Stress and Insomnia

Exclusion Criteria

* Persons with severe mental illness that are confined to mental hospitals etc. as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM) are excluded from this clinical trial.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GAAD Medical Research Institute Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

GAAD Medical research Institute Inc.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kwasi Donyina, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

GAAD Medical Research Institute Inc.

Ken Nedd, M.D.

Role: STUDY_DIRECTOR

GAAD Medical Research Institute Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Centre for Incurable Diseases

Mississauga, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GAAD-BPC-CTP1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neurofeedback for Bipolar Disorder
NCT05802446 RECRUITING NA
Time Restricted Eating (TRE) in Bipolar Disorder
NCT07211217 NOT_YET_RECRUITING NA